{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"bd37f185-1871-4282-89b9-4b51b5b8898b","metadata_created":"2021-06-21T18:21:13.295270","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-09-27T19:41:18.860156","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-21","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","SRAS-CoV-2","test sérologique","algorithmes","sérologie","risques","de transmission","rassemblements","modélisation","mathématique","RT-PCR","faux négatifs","réinfection","nouvelle analyse","grippe","dépistage","interventions","santé publique","chlamydia","gonorrhée","grossesse","prénatal","éclosion","service personnel","santé publique","prévention","contrôle","l’infection","gestion","des cas","contacts","événement","supercontamination","VHC","contamination","épidémie","établissements","de soins","de santé","externes","politique","publique","favorable","à la santé","transfert","des connaissances","rétablissement","RMTC"],"en":["COVID-19","SARS-CoV-2","serological testing","serology algorithms","transmission risk","gatherings","mathematical modelling","RT-PCR","false-negative","reinfection","retesting","influenza","testing","public health interventions","Canada","chlamydia","gonorrhea","screening","pregnancy","prenatal","outbreak","personal service setting","public health","infection","prevention","control","case","contact","management","superspreading","event","HCV","practices","IPAC","contamination","out-of-hospital","healthcare","settings","healthy","public policy","knowledge","translation","recovery","ethics","immunization","health law","CCDR"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"RMTC : Volume 47-4, avril 2021 : COVID-19 : un an après","en":"CCDR: Volume 47-4, April 2021: COVID-19: A Year Later"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"daa47a95-08c2-43ed-b401-46af9824dcbd","related_relationship":"","name_translated":{"fr":"RMTC : Volume 47-4, avril 2021 : COVID-19 : un an après","en":"CCDR: Volume 47-4, April 2021: COVID-19: A Year Later"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 47-4, April 2021: COVID-19: A Year Later","language":["en"],"created":"2021-06-21T18:21:13.394976","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021.html","last_modified":null,"position":0,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"370f63a6-8de4-4db6-b5d2-0964097cb424","related_relationship":"","name_translated":{"fr":"RMTC : Volume 47-4, avril 2021 : COVID-19 : un an après","en":"CCDR: Volume 47-4, April 2021: COVID-19: A Year Later"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 47-4, April 2021: COVID-19: A Year Later","language":["fr"],"created":"2021-06-21T18:21:13.394982","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021.html","last_modified":null,"position":1,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ef81070a-584d-4b00-98d7-c052caa8bbf6","related_relationship":"","name_translated":{"fr":"Guide pratique à l’intention des laboratoires cliniques pour les tests de sérologie du SRAS-CoV-2","en":"Practical guidance for clinical laboratories for SARS-CoV-2 serology testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Practical guidance for clinical laboratories for SARS-CoV-2 serology testing","language":["en"],"created":"2021-06-21T18:21:13.394985","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/laboratory-guidance-sars-cov-2-testing.html","last_modified":null,"position":2,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"de121bd5-cf77-4eb7-a258-d63fc21bc925","related_relationship":"","name_translated":{"fr":"Guide pratique à l’intention des laboratoires cliniques pour les tests de sérologie du SRAS-CoV-2","en":"Practical guidance for clinical laboratories for SARS-CoV-2 serology testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Practical guidance for clinical laboratories for SARS-CoV-2 serology testing","language":["fr"],"created":"2021-06-21T18:21:13.394987","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/guide-laboratoires-depistage-sras-cov-2.html","last_modified":null,"position":3,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cdcdf8ee-7769-42af-a786-d8e8e5b5141f","related_relationship":"","name_translated":{"fr":"Méthodes simples de modélisation mathématique pour évaluer le risque de transmission du SRAS-CoV-2 pendant les rassemblements","en":"Simple mathematical modelling approaches to assessing the transmission risk of SARS-CoV-2 at gatherings"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Simple mathematical modelling approaches to assessing the transmission risk of SARS-CoV-2 at gatherings","language":["en"],"created":"2021-06-21T18:21:13.394989","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/assessing-risk-transmission-sars-cov-2-gatherings.html","last_modified":null,"position":4,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a996c1d9-c116-4233-85c8-e9d00b7a7ebe","related_relationship":"","name_translated":{"fr":"Méthodes simples de modélisation mathématique pour évaluer le risque de transmission du SRAS-CoV-2 pendant les rassemblements","en":"Simple mathematical modelling approaches to assessing the transmission risk of SARS-CoV-2 at gatherings"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Simple mathematical modelling approaches to assessing the transmission risk of SARS-CoV-2 at gatherings","language":["fr"],"created":"2021-06-21T18:21:13.394991","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/evaluer-risque-transmission-sras-cov-2-rassemblements.html","last_modified":null,"position":5,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f6b9ae93-b6dc-40c4-9cc3-3e9985ccd0ea","related_relationship":"","name_translated":{"fr":"Réponse immunitaire sérique chez les patients rétablis de la COVID-19 dont le résultat à un test subséquent est positif","en":"Serum antibody response in COVID-19-recovered patients who retested positive"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Serum antibody response in COVID-19-recovered patients who retested positive","language":["en"],"created":"2021-06-21T18:21:13.394993","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/covid-19-negative-patients-retested-positive.html","last_modified":null,"position":6,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"58c08b2a-7f1d-4af4-b02b-7626eadc9558","related_relationship":"","name_translated":{"fr":"Réponse immunitaire sérique chez les patients rétablis de la COVID-19 dont le résultat à un test subséquent est positif","en":"Serum antibody response in COVID-19-recovered patients who retested positive"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Serum antibody response in COVID-19-recovered patients who retested positive","language":["fr"],"created":"2021-06-21T18:21:13.394995","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/patients-diagnostic-negatif-covid-19-nouveau-resultat-test-positif.html","last_modified":null,"position":7,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cd1bbc1e-6448-41f3-b01c-a6a21c8b4591","related_relationship":"","name_translated":{"fr":"Disparition rapide de la grippe après la mise en œuvre de mesures d'atténuation de la COVID-19 à Hamilton, Ontario","en":"Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario","language":["en"],"created":"2021-06-21T18:21:13.394997","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/influenza-vanishing-covid-19-measures-hamilton-ontario.html","last_modified":null,"position":8,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d9b64142-3b1a-431c-9cba-d0618819d3a2","related_relationship":"","name_translated":{"fr":"Disparition rapide de la grippe après la mise en œuvre de mesures d'atténuation de la COVID-19 à Hamilton, Ontario","en":"Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario","language":["fr"],"created":"2021-06-21T18:21:13.394999","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/grippe-disparait-mesures-covid-19-hamilton-ontario.html","last_modified":null,"position":9,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b06d0e52-9ef2-42c6-91da-0562df5ba950","related_relationship":"","name_translated":{"fr":"Dépistage prénatal sous-optimal des infections à Chlamydia trachomatis et Neisseria gonorrhoeae dans un centre des naissances et de soins tertiaires de Montréal : une étude de cohorte rétrospective","en":"Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: A retrospective cohort study"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: A retrospective cohort study","language":["en"],"created":"2021-06-21T18:21:13.395002","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/suboptimal-prenatal-screening-chlamydia-gonorrhoeae-montreal-quebec.html","last_modified":null,"position":10,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"df50f83e-4611-48f6-8105-35cfd12d1543","related_relationship":"","name_translated":{"fr":"Dépistage prénatal sous-optimal des infections à Chlamydia trachomatis et Neisseria gonorrhoeae dans un centre des naissances et de soins tertiaires de Montréal : une étude de cohorte rétrospective","en":"Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: A retrospective cohort study"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: A retrospective cohort study","language":["fr"],"created":"2021-06-21T18:21:13.395004","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/depistage-prental-sous-optimal-chlamydia-gonorrhoeae-montreal-quebec.html","last_modified":null,"position":11,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b3f8da70-4df9-40ae-9a5d-1dff8f8df1b6","related_relationship":"","name_translated":{"fr":"Éclosion de COVID-19 dans un établissement de services personnels à Kingston, Ontario en 2020","en":"COVID-19 outbreak in a personal service setting in Kingston, Ontario, 2020"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 outbreak in a personal service setting in Kingston, Ontario, 2020","language":["en"],"created":"2021-06-21T18:21:13.395006","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/covid-19-outbreak-kingston-ontario-2020.html","last_modified":null,"position":12,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"661e43ea-ce8b-48f1-8b6f-15e7fe729d3b","related_relationship":"","name_translated":{"fr":"Éclosion de COVID-19 dans un établissement de services personnels à Kingston, Ontario en 2020","en":"COVID-19 outbreak in a personal service setting in Kingston, Ontario, 2020"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 outbreak in a personal service setting in Kingston, Ontario, 2020","language":["fr"],"created":"2021-06-21T18:21:13.395008","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/eclosion-covid-19-kingston-ontario-2020.html","last_modified":null,"position":13,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c891d7e5-b13f-4dc2-914f-5834172e82c4","related_relationship":"","name_translated":{"fr":"Une éclosion du virus de l'hépatite C attribuée à l'utilisation de flacons à doses multiples dans une clinique de coloscopie de la région de Waterloo, en Ontario","en":"An outbreak of hepatitis C virus attributed to the use of multi-dose vials at a colonoscopy clinic, Waterloo Region, Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"An outbreak of hepatitis C virus attributed to the use of multi-dose vials at a colonoscopy clinic, Waterloo Region, Ontario","language":["en"],"created":"2021-06-21T18:21:13.395010","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/hepatitis-c-outbreak-colonoscopy-clinic-ontario.html","last_modified":null,"position":14,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"67c6ea21-011a-42ad-8821-a8f71294fdac","related_relationship":"","name_translated":{"fr":"Une éclosion du virus de l'hépatite C attribuée à l'utilisation de flacons à doses multiples dans une clinique de coloscopie de la région de Waterloo, en Ontario","en":"An outbreak of hepatitis C virus attributed to the use of multi-dose vials at a colonoscopy clinic, Waterloo Region, Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"An outbreak of hepatitis C virus attributed to the use of multi-dose vials at a colonoscopy clinic, Waterloo Region, Ontario","language":["fr"],"created":"2021-06-21T18:21:13.395012","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/eclosion-hepatite-c-clinique-coloscopie-ontario.html","last_modified":null,"position":15,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c467d0fe-6f01-42f5-902e-c12d36861144","related_relationship":"","name_translated":{"fr":"Le Centre de collaboration nationale sur les politiques publiques et la santé au temps de la COVID-19 : développer les compétences pour « rebâtir en mieux »","en":"The National Collaborating Centre for Healthy Public Policy in times of COVID-19: Building skills to \"Build Back Better\""},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The National Collaborating Centre for Healthy Public Policy in times of COVID-19: Building skills to \"Build Back Better\"","language":["en"],"created":"2021-06-21T18:21:13.395014","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/national-collaborating-centre-healthy-public-policy-build-canada-after-covid-19.html","last_modified":null,"position":16,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"06f6adf0-fa15-4d04-b956-cc110c647b42","related_relationship":"","name_translated":{"fr":"Le Centre de collaboration nationale sur les politiques publiques et la santé au temps de la COVID-19 : développer les compétences pour « rebâtir en mieux »","en":"The National Collaborating Centre for Healthy Public Policy in times of COVID-19: Building skills to \"Build Back Better\""},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The National Collaborating Centre for Healthy Public Policy in times of COVID-19: Building skills to \"Build Back Better\"","language":["fr"],"created":"2021-06-21T18:21:13.395016","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/centre-collaboration-nationale-politiques-publiques-sante-canada-rebatir-apres-covid-19.html","last_modified":null,"position":17,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3be97ce6-d1ea-4f4d-ae96-f45939f773ba","related_relationship":"","name_translated":{"fr":"Examen déontologique des programmes d’immunisation de la santé publique au Canada","en":"Ethics check-up of public health immunization programs in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Ethics check-up of public health immunization programs in Canada","language":["en"],"created":"2021-06-21T18:21:13.395018","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/assessing-canada-public-health-immunization-programs.html","last_modified":null,"position":18,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"49273c7f-9e84-4d21-a64b-1a20470de633","related_relationship":"","name_translated":{"fr":"Examen déontologique des programmes d’immunisation de la santé publique au Canada","en":"Ethics check-up of public health immunization programs in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Ethics check-up of public health immunization programs in Canada","language":["fr"],"created":"2021-06-21T18:21:13.395020","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/evaluation-programmes-immunisation-sante-publique-canada.html","last_modified":null,"position":19,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2e0b7a22-2c43-40f2-8096-a895535e2ead","related_relationship":"","name_translated":{"fr":"Immunité protectrice après une infection par la COVID-19","en":"Protective immunity post-COVID-19 infection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Protective immunity post-COVID-19 infection","language":["en"],"created":"2021-06-21T18:21:13.395022","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/post-covid-19-immunity.html","last_modified":null,"position":20,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"bd37f185-1871-4282-89b9-4b51b5b8898b","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6cd6de81-3652-4068-a2e1-3a826d498817","related_relationship":"","name_translated":{"fr":"Immunité protectrice après une infection par la COVID-19","en":"Protective immunity post-COVID-19 infection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Protective immunity post-COVID-19 infection","language":["fr"],"created":"2021-06-21T18:21:13.395024","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/immunite-post-covid-19.html","last_modified":null,"position":21,"revision_id":"0dc6d7e4-5a76-4fad-9cc2-955cbde5fc24","resource_type":"website"}],"place_of_publication":[],"num_resources":22,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2021-04-30 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"bd37f185-1871-4282-89b9-4b51b5b8898b","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 47-4, April 2021: COVID-19: A Year Later","revision_id":"038e28f1-893b-4fff-b097-9e7ba1d31d10"}